Skip to main content

Table 1 Baseline characteristics of 130 unique IBD patients admitted to MVMC between 2007 and 2013 (n = 130)

From: Risk factors for 90-day readmission in veterans with inflammatory bowel disease—Does post-discharge follow-up matter?

Item Value
Age (year, x ± s) 59.8 ± 15.2
Male (n (%)) 125 (96.2)
Caucasian (n (%)) 118 (90.8)
History of psychiatric disorder 66 (50.8)
Type of IBD (n (%))
 Crohn’s disease 74 (56.9)
 Ulcerative colitis 56 (43.1)
Duration of IBD (year, median(IQR)) 15 (5.0-30.3)
History of bowel resection (n (%)) 75 (57.7)
IBD medication prior to admission (n (%))
 5-ASA 45 (34.6)
 Immunomodulator (AZA/6-MP or MTX) 27 (20.8)
 Anti-TNF 12 (9.2)
 Steroids 25 (19.2)
Patient who has not been on IBD medication prior to admission (n (%)) 37 (28.5)
  1. MVMC Minneapolis VA Medical Center, IBD inflammatory bowel disease, IQR interquartile range, ASA aminosalicylic acid, AZA azathioprine, 6-MP 6 Mercaptopurine, MTX methotrexate, TNF tumor necrosis factor